Atlas Capital Advisors LLC Amgen Inc Transaction History

Atlas Capital Advisors LLC

$800 Billion
Q1 2025

A detailed history of Atlas Capital Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Atlas Capital Advisors LLC holds 6,752 shares of AMGN stock, worth $1.95 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

6,752

Previous 6,752 -0.0%

Holding current value

$1.95 Million

Previous $1.76 Billion 19.53%

% of portfolio

0.26%

Previous 0.22%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$258.78 - $328.31 $1.43 Million - $1.82 Million	5,537 Added 455.72%	6,752 $1.76 Billion
Q3 2024 Nov 05, 2024	SELL	$309.38 - $337.38 $1.69 Million - $1.84 Million	-5,455 Reduced 81.78%	1,215 $391 Million
Q2 2024 Jul 29, 2024	BUY	$262.75 - $319.31 $1.39 Million - $1.69 Million	5,289 Added 382.98%	6,670 $2.08 Billion
Q1 2024 Apr 15, 2024	SELL	$268.87 - $324.56 $1.49 Million - $1.79 Million	-5,524 Reduced 80.0%	1,381 $393 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $21,865 - $27,145	100 Added 1.47%	6,905 $1.86 Billion
Q2 2023 Aug 15, 2023	SELL	$214.27 - $253.37 $2,785 - $3,293	-13 Reduced 0.19%	6,805 $1.51 Billion
Q1 2023 May 16, 2023	SELL	$225.79 - $275.2 $3,161 - $3,852	-14 Reduced 0.2%	6,818 $1.65 Billion
Q4 2022 Feb 15, 2023	SELL	$229.03 - $291.01 $58,173 - $73,916	-254 Reduced 3.58%	6,832 $1.79 Billion
Q3 2022 Nov 08, 2022	BUY	$224.46 - $253.15 $2,917 - $3,290	13 Added 0.18%	7,086 $1.6 Billion
Q2 2022 Aug 16, 2022	SELL	$230.71 - $256.74 $7,844 - $8,729	-34 Reduced 0.48%	7,073 $1.72 Billion
Q1 2022 May 11, 2022	BUY	$219.27 - $242.57 $17,322 - $19,163	79 Added 1.12%	7,107 $1.72 Billion
Q4 2021 Feb 01, 2022	SELL	$198.88 - $227.6 $49,720 - $56,900	-250 Reduced 3.44%	7,028 $1.58 Billion
Q3 2021 Oct 28, 2021	SELL	$212.27 - $248.7 $63,681 - $74,610	-300 Reduced 3.96%	7,278 $1.55 Million
Q2 2021 Jul 30, 2021	BUY	$233.58 - $259.14 $7,240 - $8,033	31 Added 0.41%	7,578 $1.85 Million
Q1 2021 May 10, 2021	BUY	$221.91 - $258.6 $55,477 - $64,650	250 Added 3.43%	7,547 $1.88 Million
Q3 2020 Oct 23, 2020	SELL	$234.65 - $260.95 $68,048 - $75,675	-290 Reduced 3.82%	7,297 $1.85 Million
Q2 2020 Jul 28, 2020	SELL	$197.81 - $242.74 $11,472 - $14,078	-58 Reduced 0.76%	7,587 $1.79 Million
Q3 2019 Nov 01, 2019	BUY	$174.11 - $208.62 $37,085 - $44,436	213 Added 2.87%	7,645 $1.48 Million
Q2 2019 Jul 25, 2019	SELL	$166.7 - $195.41 $4,667 - $5,471	-28 Reduced 0.38%	7,432 $0
Q1 2019 Apr 29, 2019	BUY	$180.87 - $203.88 $5,064 - $5,708	28 Added 0.38%	7,460 $0
Q1 2018 Apr 18, 2018	BUY	$169.43 - $198.0 $1.26 Million - $1.47 Million	7,432 New	7,432 $0

Others Institutions Holding AMGN

# of Institutions

3,309

Shares Held

429M

Call Options Held

8.06M

Put Options Held

7.7M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $154B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlas Capital Advisors LLC with notifications on news.

Account

Atlas Capital Advisors LLC Amgen Inc Transaction History